APOLLOMICS INC (APLM) Stock Price, Quote, News and Overview
NASDAQ:APLM - Nasdaq - KYG0411D1079 - Common Stock - Currency: USD
APLM Quote, Performance and Key Statistics
NASDAQ:APLM (3/7/2025, 8:05:14 PM)
6.39
+0.08 (+1.27%)
The current stock price of APLM is 6.39 USD. In the past month the price decreased by -23.01%. In the past year, price decreased by -91.42%.
APLM Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.17 | 378.30B | ||
| AMGN | AMGEN INC | 16.39 | 174.51B | ||
| GILD | GILEAD SCIENCES INC | 25.47 | 146.22B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1683.76 | 125.39B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.5 | 77.34B | ||
| ARGX | ARGENX SE - ADR | 231.21 | 36.10B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.66B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.47B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.08B | ||
| BIIB | BIOGEN INC | 9.13 | 22.01B | ||
| NTRA | NATERA INC | N/A | 19.02B | ||
| GMAB | GENMAB A/S -SP ADR | 24.89 | 15.34B |
Related stock screener links
About APLM
Company Profile
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company is headquartered in Foster City, California and currently employs 45 full-time employees. The company went IPO on 2021-11-26. The firm uses both targeted, immuno-oncology, and other approaches to address a range of cancer indications, such as acute myeloid leukemia, lung cancer, brain cancer, and other solid tumors. The product candidates in its pipeline are categorized into three groups based on their mechanisms of action, each of which contains product candidates at different stages of development: tumour inhibitors, anti-cancer enhancers, and immuno-oncology drugs. Its advanced product candidate is vebreltinib (APL-101), a potent, oral active, highly selective c-Met inhibitor. Its anti-cancer enhancer product candidates include uproleselan (APL-106) and are antagonists of a cell adhesion receptor called E-selectin. Its immuno-oncology product candidates consist of APL-501, APL-502, APL-801 and APL-810. Its other product candidates include APL-122, APL-102, and APL-108.
Company Info
APOLLOMICS INC
989 East Hillsdale Blvd, Ste 220
Foster City CALIFORNIA US
Employees: 45
Company Website: https://www.apollomicsinc.com
Investor Relations: https://ir.apollomicsinc.com/
Phone: 16502094055
APOLLOMICS INC / APLM FAQ
What is the stock price of APOLLOMICS INC today?
The current stock price of APLM is 6.39 USD. The price increased by 1.27% in the last trading session.
What is the ticker symbol for APOLLOMICS INC stock?
The exchange symbol of APOLLOMICS INC is APLM and it is listed on the Nasdaq exchange.
On which exchange is APLM stock listed?
APLM stock is listed on the Nasdaq exchange.
What is APOLLOMICS INC worth?
APOLLOMICS INC (APLM) has a market capitalization of 7.03M USD. This makes APLM a Nano Cap stock.
How many employees does APOLLOMICS INC have?
APOLLOMICS INC (APLM) currently has 45 employees.
What are the support and resistance levels for APOLLOMICS INC (APLM) stock?
APOLLOMICS INC (APLM) has a resistance level at 6.55. Check the full technical report for a detailed analysis of APLM support and resistance levels.
Is APOLLOMICS INC (APLM) expected to grow?
The Revenue of APOLLOMICS INC (APLM) is expected to decline by -100% in the next year. Check the estimates tab for more information on the APLM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy APOLLOMICS INC (APLM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APLM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APLM, evaluating the profitability, health, valuation and growth aspects
- APOLLOMICS INC (APLM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APOLLOMICS INC (APLM) Sales and EPS estimates to see what analysts future expectations are.
- APOLLOMICS INC (APLM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APOLLOMICS INC (APLM) Insider and Institutional Ownership to learn about the owners and their transactions.
- APOLLOMICS INC (APLM) Stock Chart to make your own analysis
- APOLLOMICS INC (APLM) Latest news and press-releases to stay up to date.
Does APOLLOMICS INC (APLM) stock pay dividends?
APLM does not pay a dividend.
What is the Price/Earnings (PE) ratio of APOLLOMICS INC (APLM)?
APOLLOMICS INC (APLM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.93).
What is the Short Interest ratio of APOLLOMICS INC (APLM) stock?
The outstanding short interest for APOLLOMICS INC (APLM) is 1.05% of its float. Check the ownership tab for more information on the APLM short interest.
APLM Technical Analysis
APLM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to APLM. Both the profitability and financial health of APLM have multiple concerns.
APLM Financial Highlights
Over the last trailing twelve months APLM reported a non-GAAP Earnings per Share(EPS) of -1.93. The EPS decreased by -3757.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -311.63% | ||
| ROE | -418.59% | ||
| Debt/Equity | 0.01 |
APLM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to APLM. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 99.53% and a revenue growth -100% for APLM